Indeed, it has been shown that ketamine increases the effectiveness of the signaling induced by opiates47 and in a very recent randomized controlled trial48, they found that reduction of depression was lower when naltrexone (an MOR antagonist), versus placebo, was administered before ketamine administration. This evidence concerns the gene OPRM1 and depressive disorder.